NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
0.5100
-0.0320 (-5.90%)
At close: May 15, 2026, 4:00 PM EDT
0.5119
+0.0019 (0.37%)
After-hours: May 15, 2026, 6:23 PM EDT
NEXGEL Market Cap
NEXGEL has a market cap or net worth of $4.32 million as of May 15, 2026. Its market cap has decreased by -78.44% in one year.
Market Cap
4.32M
Enterprise Value
8.40M
1-Year Change
-78.44%
Ranking
Category
Stock Price
$0.51
Market Cap Chart
Since the IPO on December 22, 2021, NEXGEL's market cap has decreased from $19.59M to $4.32M, a decrease of -77.93%. That is a compound annual growth rate of -29.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 4.32M | -67.03% |
| Dec 31, 2025 | 13.11M | -60.90% |
| Dec 31, 2024 | 33.53M | 175.32% |
| Dec 29, 2023 | 12.18M | 74.85% |
| Dec 30, 2022 | 6.97M | -52.05% |
| Dec 31, 2021 | 14.52M | -25.85% |
| Dec 22, 2021 | 19.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nephros | 36.26M |
| Milestone Scientific | 29.66M |
| Harvard Bioscience | 24.90M |
| Femasys | 22.98M |
| Retractable Technologies | 20.66M |
| Jin Medical International | 19.26M |
| Bionano Genomics | 13.20M |
| Regentis Biomaterials | 10.62M |